Cargando…
The Kinetics of Amyloid Fibril Formation by de Novo Protein Albebetin and Its Mutant Variants
Engineering of amyloid structures is one of the new perspective areas of protein engineering. Studying the process of amyloid formation can help find ways to manage it in the interests of medicine and biotechnology. One of the promising candidates for the structural basis of artificial functional am...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072675/ https://www.ncbi.nlm.nih.gov/pubmed/32033353 http://dx.doi.org/10.3390/biom10020241 |
_version_ | 1783506461742071808 |
---|---|
author | Balobanov, Vitalii Chertkova, Rita Egorova, Anna Dolgikh, Dmitry Bychkova, Valentina Kirpichnikov, Mikhail |
author_facet | Balobanov, Vitalii Chertkova, Rita Egorova, Anna Dolgikh, Dmitry Bychkova, Valentina Kirpichnikov, Mikhail |
author_sort | Balobanov, Vitalii |
collection | PubMed |
description | Engineering of amyloid structures is one of the new perspective areas of protein engineering. Studying the process of amyloid formation can help find ways to manage it in the interests of medicine and biotechnology. One of the promising candidates for the structural basis of artificial functional amyloid fibrils is albebetin (ABB), an artificial protein engineered under the leadership of O.B. Ptitsyn. Various aspects of the amyloid formation of this protein and some methods for controlling this process are investigated in this paper. Four stages of amyloid fibrils formation by this protein from the first non-fibrillar aggregates to mature fibrils and large micron-sized complexes have been described in detail. Dependence of albebetin amyloids formation on external conditions and some mutations also have been described. The introduction of similar point mutations in the two structurally identical α-β-β motifs of ABB lead to different amiloidogenesis kinetics. The inhibitory effect of a disulfide bond and high pH on amyloid fibrils formation, that can be used to control this process, was shown. The results of this work are a good basis for the further design and use of ABB-based amyloid constructs. |
format | Online Article Text |
id | pubmed-7072675 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70726752020-03-19 The Kinetics of Amyloid Fibril Formation by de Novo Protein Albebetin and Its Mutant Variants Balobanov, Vitalii Chertkova, Rita Egorova, Anna Dolgikh, Dmitry Bychkova, Valentina Kirpichnikov, Mikhail Biomolecules Article Engineering of amyloid structures is one of the new perspective areas of protein engineering. Studying the process of amyloid formation can help find ways to manage it in the interests of medicine and biotechnology. One of the promising candidates for the structural basis of artificial functional amyloid fibrils is albebetin (ABB), an artificial protein engineered under the leadership of O.B. Ptitsyn. Various aspects of the amyloid formation of this protein and some methods for controlling this process are investigated in this paper. Four stages of amyloid fibrils formation by this protein from the first non-fibrillar aggregates to mature fibrils and large micron-sized complexes have been described in detail. Dependence of albebetin amyloids formation on external conditions and some mutations also have been described. The introduction of similar point mutations in the two structurally identical α-β-β motifs of ABB lead to different amiloidogenesis kinetics. The inhibitory effect of a disulfide bond and high pH on amyloid fibrils formation, that can be used to control this process, was shown. The results of this work are a good basis for the further design and use of ABB-based amyloid constructs. MDPI 2020-02-05 /pmc/articles/PMC7072675/ /pubmed/32033353 http://dx.doi.org/10.3390/biom10020241 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Balobanov, Vitalii Chertkova, Rita Egorova, Anna Dolgikh, Dmitry Bychkova, Valentina Kirpichnikov, Mikhail The Kinetics of Amyloid Fibril Formation by de Novo Protein Albebetin and Its Mutant Variants |
title | The Kinetics of Amyloid Fibril Formation by de Novo Protein Albebetin and Its Mutant Variants |
title_full | The Kinetics of Amyloid Fibril Formation by de Novo Protein Albebetin and Its Mutant Variants |
title_fullStr | The Kinetics of Amyloid Fibril Formation by de Novo Protein Albebetin and Its Mutant Variants |
title_full_unstemmed | The Kinetics of Amyloid Fibril Formation by de Novo Protein Albebetin and Its Mutant Variants |
title_short | The Kinetics of Amyloid Fibril Formation by de Novo Protein Albebetin and Its Mutant Variants |
title_sort | kinetics of amyloid fibril formation by de novo protein albebetin and its mutant variants |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072675/ https://www.ncbi.nlm.nih.gov/pubmed/32033353 http://dx.doi.org/10.3390/biom10020241 |
work_keys_str_mv | AT balobanovvitalii thekineticsofamyloidfibrilformationbydenovoproteinalbebetinanditsmutantvariants AT chertkovarita thekineticsofamyloidfibrilformationbydenovoproteinalbebetinanditsmutantvariants AT egorovaanna thekineticsofamyloidfibrilformationbydenovoproteinalbebetinanditsmutantvariants AT dolgikhdmitry thekineticsofamyloidfibrilformationbydenovoproteinalbebetinanditsmutantvariants AT bychkovavalentina thekineticsofamyloidfibrilformationbydenovoproteinalbebetinanditsmutantvariants AT kirpichnikovmikhail thekineticsofamyloidfibrilformationbydenovoproteinalbebetinanditsmutantvariants AT balobanovvitalii kineticsofamyloidfibrilformationbydenovoproteinalbebetinanditsmutantvariants AT chertkovarita kineticsofamyloidfibrilformationbydenovoproteinalbebetinanditsmutantvariants AT egorovaanna kineticsofamyloidfibrilformationbydenovoproteinalbebetinanditsmutantvariants AT dolgikhdmitry kineticsofamyloidfibrilformationbydenovoproteinalbebetinanditsmutantvariants AT bychkovavalentina kineticsofamyloidfibrilformationbydenovoproteinalbebetinanditsmutantvariants AT kirpichnikovmikhail kineticsofamyloidfibrilformationbydenovoproteinalbebetinanditsmutantvariants |